These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 32179276)

  • 1. A novel variant of RyR2 gene in a family misdiagnosed as congenital long QT syndrome: The importance of genetic testing.
    Letsas KP; Prappa E; Bazoukis G; Lioni L; Pantou MP; Gourzi P; Degiannis D; Sideris A
    J Electrocardiol; 2020; 60():8-11. PubMed ID: 32179276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spectrum and prevalence of cardiac ryanodine receptor (RyR2) mutations in a cohort of unrelated patients referred explicitly for long QT syndrome genetic testing.
    Tester DJ; Kopplin LJ; Will ML; Ackerman MJ
    Heart Rhythm; 2005 Oct; 2(10):1099-105. PubMed ID: 16188589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel cardiac ryanodine receptor gene (RyR2) mutation in an athlete with aborted sudden cardiac death: a case of adult-onset catecholaminergic polymorphic ventricular tachycardia.
    Arakawa J; Hamabe A; Aiba T; Nagai T; Yoshida M; Touya T; Ishigami N; Hisadome H; Katsushika S; Tabata H; Miyamoto Y; Shimizu W
    Heart Vessels; 2015 Nov; 30(6):835-40. PubMed ID: 25092222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catecholaminergic Polymorphic Ventricular Tachycardia with QT Prolongation.
    Tanaka Y; Kawabata M; Scheinman MM; Hirao K
    Pacing Clin Electrophysiol; 2015 Dec; 38(12):1499-502. PubMed ID: 26256814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss-of-function mutations in cardiac ryanodine receptor channel cause various types of arrhythmias including long QT syndrome.
    Hirose S; Murayama T; Tetsuo N; Hoshiai M; Kise H; Yoshinaga M; Aoki H; Fukuyama M; Wuriyanghai Y; Wada Y; Kato K; Makiyama T; Kimura T; Sakurai T; Horie M; Kurebayashi N; Ohno S
    Europace; 2022 Mar; 24(3):497-510. PubMed ID: 34661651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postmortem molecular analysis for fatal arrhythmogenic disease in sudden unexplained death.
    Nishio H; Suzuki K
    Leg Med (Tokyo); 2009 Apr; 11 Suppl 1():S119-20. PubMed ID: 19261510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left cardiac sympathetic denervation for the management of life-threatening ventricular tachyarrhythmias in young patients with catecholaminergic polymorphic ventricular tachycardia and long QT syndrome.
    Schneider HE; Steinmetz M; Krause U; Kriebel T; Ruschewski W; Paul T
    Clin Res Cardiol; 2013 Jan; 102(1):33-42. PubMed ID: 22821214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postpacing abnormal repolarization in catecholaminergic polymorphic ventricular tachycardia associated with a mutation in the cardiac ryanodine receptor gene.
    Nof E; Belhassen B; Arad M; Bhuiyan ZA; Antzelevitch C; Rosso R; Fogelman R; Luria D; El-Ani D; Mannens MM; Viskin S; Eldar M; Wilde AA; Glikson M
    Heart Rhythm; 2011 Oct; 8(10):1546-52. PubMed ID: 21699856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel RYR2 loss-of-function mutation (I4855M) is associated with left ventricular non-compaction and atypical catecholaminergic polymorphic ventricular tachycardia.
    Roston TM; Guo W; Krahn AD; Wang R; Van Petegem F; Sanatani S; Chen SR; Lehman A
    J Electrocardiol; 2017; 50(2):227-233. PubMed ID: 27646203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The RYR2-encoded ryanodine receptor/calcium release channel in patients diagnosed previously with either catecholaminergic polymorphic ventricular tachycardia or genotype negative, exercise-induced long QT syndrome: a comprehensive open reading frame mutational analysis.
    Medeiros-Domingo A; Bhuiyan ZA; Tester DJ; Hofman N; Bikker H; van Tintelen JP; Mannens MM; Wilde AA; Ackerman MJ
    J Am Coll Cardiol; 2009 Nov; 54(22):2065-74. PubMed ID: 19926015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia.
    Priori SG; Napolitano C; Memmi M; Colombi B; Drago F; Gasparini M; DeSimone L; Coltorti F; Bloise R; Keegan R; Cruz Filho FE; Vignati G; Benatar A; DeLogu A
    Circulation; 2002 Jul; 106(1):69-74. PubMed ID: 12093772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bradycardia Is a Specific Phenotype of Catecholaminergic Polymorphic Ventricular Tachycardia Induced by RYR2 Mutations.
    Miyata K; Ohno S; Itoh H; Horie M
    Intern Med; 2018 Jul; 57(13):1813-1817. PubMed ID: 29434162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic screening in sudden cardiac death in the young can save future lives.
    Stattin EL; Westin IM; Cederquist K; Jonasson J; Jonsson BA; Mörner S; Norberg A; Krantz P; Wisten A
    Int J Legal Med; 2016 Jan; 130(1):59-66. PubMed ID: 26228265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms and clinical management of inherited channelopathies: long QT syndrome, Brugada syndrome, catecholaminergic polymorphic ventricular tachycardia, and short QT syndrome.
    Kaufman ES
    Heart Rhythm; 2009 Aug; 6(8 Suppl):S51-5. PubMed ID: 19631908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Description of a novel RyR2 mutation in a juvenile patient with symptomatic catecholaminergic polymorphic ventricular tachycardia in sleep and during exercise: a case report.
    Seidlmayer LK; Riediger F; Pagonas N; Nordbeck P; Ritter O; Sasko B
    J Med Case Rep; 2018 Oct; 12(1):298. PubMed ID: 30296944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential Diagnosis Between Catecholaminergic Polymorphic Ventricular Tachycardia and Long QT Syndrome Type 1　- Modified Schwartz Score.
    Ozawa J; Ohno S; Fujii Y; Makiyama T; Suzuki H; Saitoh A; Horie M
    Circ J; 2018 Aug; 82(9):2269-2276. PubMed ID: 29925740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genotypic heterogeneity and phenotypic mimicry among unrelated patients referred for catecholaminergic polymorphic ventricular tachycardia genetic testing.
    Tester DJ; Arya P; Will M; Haglund CM; Farley AL; Makielski JC; Ackerman MJ
    Heart Rhythm; 2006 Jul; 3(7):800-5. PubMed ID: 16818210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GENESIS: Gene-Specific Machine Learning Models for Variants of Uncertain Significance Found in Catecholaminergic Polymorphic Ventricular Tachycardia and Long QT Syndrome-Associated Genes.
    Draelos RL; Ezekian JE; Zhuang F; Moya-Mendez ME; Zhang Z; Rosamilia MB; Manivannan PKR; Henao R; Landstrom AP
    Circ Arrhythm Electrophysiol; 2022 Apr; 15(4):e010326. PubMed ID: 35357185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prominent QTc prolongation in a patient with a rare variant in the cardiac ryanodine receptor gene.
    Taniguchi Y; Miyazaki A; Sakaguchi H; Hayama Y; Ebishima N; Negishi J; Noritake K; Miyamoto Y; Shimizu W; Aiba T; Ohuchi H
    Heart Vessels; 2017 Feb; 32(2):229-233. PubMed ID: 27401738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sudden cardiac death in Long QT syndrome (LQTS), Brugada syndrome, and catecholaminergic polymorphic ventricular tachycardia (CPVT).
    Singh M; Morin DP; Link MS
    Prog Cardiovasc Dis; 2019; 62(3):227-234. PubMed ID: 31078562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.